Dopamine Receptor d1 anticorps (C-Term)
-
- Antigène Voir toutes Dopamine Receptor d1 (DRD1) Anticorps
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Épitope
- C-Term
-
Reactivité
- Rat, Souris
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Dopamine Receptor d1 est non-conjugé
-
Application
- Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF)
- Specificité
- Reacts with mouse and rat Dopamine Receptor D1A
- Réactivité croisée
- Lapin, Mouton
- Réactivité croisée (Details)
- Do not react with human, dog, pig, sheep, rabbit, or cow proteins. Do not cross react with D1B (D5) receptor.
- Purification
- Purified (protein A)
- Immunogène
- Recombinant rat D1 (D1A) dopamine receptor (123 residues with 23 residues near the C-terminus)
- Clone
- SG2-D1a
- Isotype
- IgG2b kappa
- Top Product
- Discover our top product DRD1 Anticorps primaire
-
-
- Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- ICC : 2 μg/mL - IF : 2 μg/mL - WB : 2 μg/mL - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.4 mg/mL
- Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C/-80 °C
- Stockage commentaire
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Antigène
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
- Autre désignation
- Dopamine D1 Receptor (DRD1 Produits)
- Synonymes
- anticorps DRD1, anticorps Dop1, anticorps D1A, anticorps DADR, anticorps DRD1A, anticorps drd1, anticorps C030036C15Rik, anticorps Drd-1, anticorps Drd1, anticorps Gpcr15, anticorps D1a, anticorps Drd1a, anticorps dopamine receptor D1, anticorps dopamine receptor, D1, anticorps dopamine receptor D1b, anticorps DRD1, anticorps Dop1, anticorps drd1b, anticorps Drd1
- Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
-